The present work aimed at the development and application of a lipid-based nanocarrier for targeted delivery of nucleic acids to glioblastoma (GBM). For this purpose, chlorotoxin (CTX), a peptide reported to bind selectively to glioma cells while showing no affinity for non-neoplastic cells, was covalently coupled to liposomes encapsulating antisense oligonucleotides (asOs) or small interfering RNAs (siRNAs). T...
| Financiadores do RCAAP | |||||||
						
							 
						
					 | 
					
						
							 
						
					 | 
					
						
							 
						
					 | 
					
						
							 
						
					 | 
					
						
							 
						
					 | 
					
						
							 
				
			 | 
			||